SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
das
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
3376
1
Obduktionsbefunde beim Corpus-Carcinom des Uterus
2
Verkehrsrecht aus der Sicht der Rechtslehre
3
Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy
4
Erhöhte Expression des Stammzellmarkers Musashi-1 im Kontext von Endometriose und Endometriumkarzinom
5
Colorimetric and electrochemical (dual) thrombin assay based on the use of a platinum nanoparticle modified metal-organic framework (type Fe-MIL-88) acting as a peroxidase mimic.
6
In vitro and in vivo inhibition of Hass avocado polyphenol oxidase enzymatic browning by paeonol, β-cyclodextrin, and paeonol:β-cyclodextrin inclusion complex.
7
Characterization of balofloxacin-stressed proteomics and identification of balofloxacin-binding proteins pre-peptidase and integration host factor in Edwardsiella tarda.
8
Effect of alloxan-induced diabetes on intestinal peptidases in the rat.
9
Effects of β-glucosidase and α-rhamnosidase on the Contents of Flavonoids, Ginkgolides, and Aroma Components in Ginkgo Tea Drink.
10
Flavonol glycosides with α-Glucosidase inhibitory activities and new flavone C-diosides from the leaves of machilus konishii
11
Bioinspired synthesis and characterization of gold nano-particles from medicinally important Periploca hydaspidis and their in vitro antioxidant and antimicrobial activity.
12
Comparison on total phenols content and antioxidant activity and inhibitory effect on α-glucosidase activity of water chestnut shells (Trapa natans shells) from different locations
13
Synthesis, activity testing and molybdenum(VI) complexation of Schiff bases derived from 2,4,6-trihydroxybenzaldehyde investigated as xanthine oxidase inhibitors.
14
α-Glucosidase inhibitory activity and in vivo antihyperglycemic effect of secondary metabolites from the leaf infusion of Ocimum campechianum mill.
15
Isolation of Chemical Constituents of Centaurea virgata Lam. and Xanthine Oxidase Inhibitory Activity of the Plant Extract and Compounds.
16
Prototype of the 3D cadastral system based on a NoSQL database and a Javascript visualization application
17
Intrinsic dynamic behavior of enzyme:substrate complexes govern the catalytic action of β-galactosidases across clan GH-A.
18
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
19
Efeito de 16 semanas de treinamento com pesos sobre a pressão arterial em mulheres normotensas e não-treinadas Effect of 16-week weight training over blood pressure in normotensive and non-trained women
20
Purification and biochemical characterization of polyphenol oxidase from soursop (Annona muricata L.) and its inactivation by microwave and ultrasound treatments.
21
TAKSONOMI BLOOM – REVISI RANAH KOGNITIF: KERANGKA LANDASAN UNTUK PEMBELAJARAN, PENGAJARAN, DAN PENILAIAN
22
Penempatan Posisi Multi Kamera Berdasarkan Gaya Sutradara Berbasis Logika Fuzzy
23
Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update.
24
Bioactive aporphine alkaloids from the stems of Dasymaschalon rostratum.
25
Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: A new class of α-glucosidase inhibitors.
26
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-D-ribofuranose 2'-Oxidase.
27
AuPt/MOF-Graphene: A Synergistic Catalyst with Surprisingly High Peroxidase-Like Activity and Its Application for HO Detection.
28
“Şar Dağı Ayakdaşları” Kitabı ve Yugoslavya’yı Anlamak
29
SİNDEMİLER YA DA SİNERJİK EPİDEMİLER: TOPLUM SAĞLIĞININ ÇAĞDAŞ TEHDİTLERİ
30
Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels
31
An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017 [Corrigendum]
32
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
33
Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018
34
A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs
35
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study
36
Spinal brucellosis in Hulunbuir, China, 2011–2016
37
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
38
Low prevalence of resistance genes in sheltered homeless population in Marseille, France, 2014–2018
39
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
40
Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
41
Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
42
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections [Corrigendum]
43
Silencing of OCH1 unveils the role of Sporothrix schenckii N-linked glycans during the host–fungus interaction
44
An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017
45
Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017
46
Health care-associated infections – an overview
47
A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) 2007–2016
48
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
49
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
50
Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus
51
Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017
52
Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
53
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
54
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
55
Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study
56
Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015
57
Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction
58
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
59
Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients
60
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
61
Overview of the development of quinolone resistance in Salmonella species in China, 2005–2016
62
Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001–2010 in Kolkata, India: role of integrons, plasmids, and topoisomerase mutations
63
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections
64
High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014
65
Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm
66
Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity
67
Staphylococcus aureus – antimicrobial resistance and the immunocompromised child
68
Update on otitis media – prevention and treatment
69
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
70
Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
71
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
72
Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
73
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
74
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
75
Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
76
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
77
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
78
Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study
79
Multielectrode phased radiofrequency ablation compared with point-by-point ablation for pulmonary vein isolation – outcomes in 539 patients
80
Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations
81
8-isorpostanes – markers for oxidative stress in obstructive sleep apnea patients with systolic dysfunction
82
Self-reported prevalence of heart attacks and strokes in Jamaica: a cross-sectional study. The Jamaica Health and Lifestyle Survey 2007–2008
83
Application of the susceptible–infected–recovered deterministic model in a GII.P17 emergent norovirus strain outbreak in Romania in 2015
84
The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials
85
“Şar Dağı Ayakdaşları” Kitabı ve Yugoslavya’yı Anlamak
86
SİNDEMİLER YA DA SİNERJİK EPİDEMİLER: TOPLUM SAĞLIĞININ ÇAĞDAŞ TEHDİTLERİ
87
Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels
88
An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017 [Corrigendum]
89
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
90
Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018
91
A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs
92
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study
93
Spinal brucellosis in Hulunbuir, China, 2011–2016
94
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
95
“Şar Dağı Ayakdaşları” Kitabı ve Yugoslavya’yı Anlamak
96
SİNDEMİLER YA DA SİNERJİK EPİDEMİLER: TOPLUM SAĞLIĞININ ÇAĞDAŞ TEHDİTLERİ
97
Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels
98
An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017 [Corrigendum]
99
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
100
Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018
101
A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs